| All | OV | Without OV | p |
Male | 79 | 74 (93.7%) | 5 (6.3%) | 0.37 |
Female | 22 | 19 (86.4%) | 3 (13.6%) | 0.37 |
Age < 50 years | 58 | 52 (89.7%) | 6 (10.3%) | 0.46 |
Age ≥ 50 years | 43 | 41 (95.3%) | 2 (4.7%) | 0.46 |
Clinical findings: |
|
|
|
|
Ascites | 90 | 83 (92.2%) | 7 (7.8%) | 1.00 |
Jaundice | 35 | 31 (88.6%) | 4 (11.4%) | 0.44 |
Large spleen | 21 | 21 (100%) | 0 (0%) | 0.12 |
Large liver | 28 | 26 (92.9%) | 2 (7.1%) | 1.00 |
Collateral venous circulation | 14 | 14 (100%) | 0 (0%) | 0.59 |
Haematemesis-Melaena | 11 | 11 (100%) | 0 (0%) | 0.59 |
Hepatic encephalopathy | 2 | 1 (50%) | 1 (50%) | 0.15 |
Etiology of cirrhosis: |
|
|
|
|
HBV | 65 | 59 (90.8%) | 6 (9.2%) | 0.67 |
HCV | 21 | 18 (85.7%) | 3 (14.3%) | 0.24 |
alcohol | 6 | 6 (100%) | 0 (0%) | 1.00 |
Complications: |
|
|
|
|
Haematemesis-Melaena | 25 | 25 (100%) | 0 (0%) | 0.19 |
hepatocellular carcinoma | 22 | 21 (95.5%) | 1 (4.5%) | 0.68 |
Liquid ascite infection | 14 | 13 (92.9%) | 1 (7.1%) | 1.00 |
Hepatic encephalopathy | 13 | 12 (92.3%) | 1 (7.7%) | 1.00 |
Hepatorenal syndrome | 2 | 2 (100%) | 0 (0%) | 1.00 |